Anticorps Recombinant de lapin anti-CD45RA

CD45RA Recombinant Antibody for FC

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

rat

Applications

FC

Conjugaison

Non conjugué

CloneNo.

OX-33

N° de cat : 65578-1-MR

Synonymes

CD45, Lca, Ptprc, L CA, OX-33



Applications testées

Résultats positifs en cytométriesplénocytes de rat

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

65578-1-MR cible CD45RA dans les applications de FC et montre une réactivité avec des échantillons rat

Réactivité rat
Hôte / Isotype Mouse / IgG2a
Clonalité Recombinant
Type Anticorps
Immunogène Leukocyte common antigen purified from rat splenocytes
Nom complet protein tyrosine phosphatase, receptor type, C
Masse moléculaire calculée143 kDa
Numéro d’acquisition GenBankXM_006249910
Symbole du gène CD45
Identification du gène (NCBI) 24699
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2-8°C. Stable for one year after shipment.

Informations générales

CD45, also known as protein tyrosine phosphatase, receptor type C, is a type I transmembrane protein expressed on the surface of all haematopoietic cells with the exception of erythrocytes and platelets (PMID: 3489673; 28615666). CD45 is a pan-haematopoietic cell marker and has been shown to be essential for T- and B-cell activation and signaling (PMID: 9429890; 16378097). CD45 exists as multiple isoforms due to alternative splicing of three exons (4, 5, and 6, designated A, B, and C) in the extracellular domain (PMID: 12414720). CD45RA is expressed on naïve T cells, B cells, and monocytes (PMID: 1830500; 14687231).

Protocole

Product Specific Protocols
FC protocol for CD45RA antibody 65578-1-MRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}